Validation of a Size-Based T-Staging Protocol for Pancreatic Ductal Adenocarcinoma After Neoadjuvant Chemoradiation Therapy

被引：0
|
作者：
Uchida, Katsunori [1 ]
Murata, Yasuhiro [1 ]
Kishiwada, Masayuki [1 ]
Isaji, Shuji [1 ]
机构：
[1] Mie Univ, Grad Sch Med, Tsu, Mie, Japan
来源：
LABORATORY INVESTIGATION | 2017年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1816
引用
收藏
页码：452A / 452A
页数：1
相关论文
共 50 条
  • [1] Validation of a Size-Based T-Staging Protocol for Pancreatic Ductal Adenocarcinoma After Neoadjuvant Chemoradiation Therapy
    Uchida, Katsunori
    Murata, Yasuhiro
    Kishiwada, Masayuki
    Isaji, Shuji
    MODERN PATHOLOGY, 2017, 30 : 452A - 452A
  • [2] A neoadjuvant therapy compatible prognostic staging for resected pancreatic ductal adenocarcinoma
    Zhu, Lingyu
    Shen, Shuo
    Wang, Huan
    Zhang, Guoxiao
    Yin, Xiaoyi
    Shi, Xiaohan
    Gao, Suizhi
    Han, Jiawei
    Ren, Yiwei
    Wang, Jian
    Jiang, Hui
    Guo, Shiwei
    Jin, Gang
    BMC CANCER, 2023, 23 (01)
  • [3] A neoadjuvant therapy compatible prognostic staging for resected pancreatic ductal adenocarcinoma
    Lingyu Zhu
    Shuo Shen
    Huan Wang
    Guoxiao Zhang
    Xiaoyi Yin
    Xiaohan Shi
    Suizhi Gao
    Jiawei Han
    Yiwei Ren
    Jian Wang
    Hui Jiang
    Shiwei Guo
    Gang Jin
    BMC Cancer, 23
  • [4] A Proposal for Improved T-Staging of Pancreatic Ductal Adenocarcinoma by Using Microscopic Examination as the Basis for Determining the Size and T-Stage
    Basturk, Olca
    Reid, Michelle
    Balci, Serdar
    Seven, Ipek Erbarut
    Saka, Burcu
    Pehlivanoglu, Burcin
    Memis, Bahar
    Bagci, Pelin
    Adsay, N. Volkan
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1634 - 1634
  • [5] A Proposal for Improved T-Staging of Pancreatic Ductal Adenocarcinoma by Using Microscopic Examination as the Basis for Determining the Size and T-Stage
    Basturk, Olca
    Reid, Michelle
    Balci, Serdar
    Seven, Ipek Erbarut
    Saka, Burcu
    Pehlivanoglu, Burcin
    Memis, Bahar
    Bagci, Pelin
    Adsay, N. Volkan
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 1634 - 1634
  • [6] Pancreatic ductal adenocarcinoma after neoadjuvant therapy: Histomorphologic characterisation
    Haeberle, L.
    Kapp, A. -C.
    Esposito, I.
    VIRCHOWS ARCHIV, 2017, 471 : S130 - S130
  • [7] MicroRNA Expression in Pancreatic Ductal Adenocarcinoma: A Comparative Study to Predict Metastasis after Neoadjuvant Chemoradiation
    Putra, Juan
    de Abreu, Francine
    York, Eric B.
    Palisoul, Scott M.
    Suriawinata, Arief A.
    Liu, Xiaoying
    Tsongalis, Gregory J.
    LABORATORY INVESTIGATION, 2016, 96 : 447A - 447A
  • [8] MicroRNA Expression in Pancreatic Ductal Adenocarcinoma: A Comparative Study to Predict Metastasis after Neoadjuvant Chemoradiation
    Putra, Juan
    de Abreu, Francine
    York, Eric B.
    Palisoul, Scott M.
    Suriawinata, Arief A.
    Liu, Xiaoying
    Tsongalis, Gregory J.
    MODERN PATHOLOGY, 2016, 29 : 447A - 447A
  • [9] Risk Factors Associated With Early Recurrence of Borderline Resectable Pancreatic Ductal Adenocarcinoma After Neoadjuvant Chemoradiation Therapy and Curative Resection
    Tsuchiya, Nobuhiro
    Matsuyama, Ryusei
    Murakami, Takashi
    Yabushita, Yasuhiro
    Sawada, Yu
    Kumamoto, Takafumi
    Endo, Itaru
    ANTICANCER RESEARCH, 2019, 39 (08) : 4431 - 4440
  • [10] Clinical outcomes of pancreatic ductal adenocarcinoma resection following neoadjuvant chemoradiation therapy vs. chemotherapy
    Satoi, Sohei
    Yanagimoto, Hiroaki
    Yamamoto, Tomohisa
    Ohe, Chisato
    Miyasaka, Chika
    Uemura, Yoshiko
    Hirooka, Satoshi
    Yamaki, So
    Ryota, Hironori
    Michiura, Taku
    Inoue, Kentaro
    Matsui, Yoichi
    Tanigawa, Noboru
    Kon, Masanori
    SURGERY TODAY, 2017, 47 (01) : 84 - 91
12345